U.S. FDA Health Press Releases — RSS Feed & Live Monitoring
PPN World tracks the U.S. FDA RSS feed in real time — 8 releases indexed over the last 30 days, the newest arrived 4 d ago. Follow it with saved-search alerts, AI summaries, and full-text search, or plug the RSS URL below into your own reader.
About this feed
U.S. FDA is one of the 1,400+ press-release feeds PPN World monitors around the clock — an English-language wire focused on Health, filed under United States in our country index. Every release is deduplicated, geotagged, and enriched with an AI summary, and you can attach saved-search alerts to any keyword it publishes. Over the last 30 days U.S. FDA has published 8 releases, busiest on Wednesdays, with recent coverage clustering around fda-approval.
Track U.S. FDA in real time in PPN World
Every U.S. FDA release lands in the cockpit seconds after it publishes — deduplicated, classified, with saved-search alerts and AI summaries, alongside 1,400+ other wires. 72-hour free trial, no card required.
Start the free trial →Latest U.S. FDA press releases
- FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia4 d ago
The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for adults and children 8 years of age and older…
- FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device4 d ago
The U.S. Food and Drug Administration today authorized the Aletta, the first standalone robotic device that can draw blood from a patient’s arm without hands-on operator intervention.
- FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices5 d ago
The U.S. Food and Drug Administration today issued a discussion paper on considerations for the regulation of generative artificial intelligence (GenAI)-enabled medical devices, seeking feedback from…
- FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies10 d ago
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel chewable tablets) for the treatment of New World screwwo…
- FDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multiple Species, Including Sheep, Cattle, Goats, and Swine16 d ago
FDA today issued an Emergency Use Authorization (EUA) for CLiK Extra (dicyclanil topical suspension) wound spray for application on or around wounds for the prevention of New World screwworm (NWS) inf…
- FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma17 d ago
The U.S. Food and Drug Administration today granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral therapy for the treatment of advanced, ref…
- FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms18 d ago
The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.
- FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.25 d ago
FDA today licensed Ezplaz Freeze Dried Plasma (FDP), making it the first freeze-dried plasma product licensed for use in the United States. Ezplaz is intended for transfusion in adult patients who nee…
- FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot32 d ago
The U.S. Food and Drug Administration today announced the first manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot.
- FDA Takes Further Steps to Remove Outdated Authorizations for Color Additives in Food32 d ago
The U.S. Food and Drug Administration today announced two actions targeting petroleum-based color additives in food, continuing the agency’s broader efforts to Make America Healthy Again.
- FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol37 d ago
The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce l…
- FDA Issues Emergency Use Authorization for Drug for Short-Term Prevention of New World Screwworm in Horses39 d ago
The FDA today issued an Emergency Use Authorization (EUA) for Ivermectin Liquid for Horses (ivermectin oral solution) for the short-term prevention of New World screwworm (NWS) infestations (myiasis)…
The newest releases on this wire stream live for PPN World members.
Frequently asked questions
How do I follow U.S. FDA press releases in real time?+
How often are U.S. FDA press releases picked up?+
What kind of press releases does U.S. FDA publish?+
Related feeds
- PR Newswire (US) — Health
- Newswise — Science News (US)
- U.S. CDC
- 24-7 Press Release — Industry: Biotechnology
- 24-7 Press Release — Industry: Healthcare
- 24-7 Press Release — Industry: Health & Fitness
- 24-7 Press Release — Medical: Addiction
- 24-7 Press Release — Medical: Aids
- 24-7 Press Release — Medical: Allergies
- 24-7 Press Release — Medical: Alternative Medicine